Gholamhossein Riazi

9PUBLICATIONS
8CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersCheminformatics and quantitative structure-activity relationshipsBiomaterialsEvolutionary impacts of climate change
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 02, 2026
Theranostic Folate-Targeted Doxorubicin-Loaded MIL-88A@CuFe2O4 Nanohybrids, a pH-Sensitive, Core-Shell, Mesoporous Drug Delivery Platform with Dual-Modal T1-T2MRI and Optical Imaging Contrast Properties: An In Vitro and In Vivo Cancer Study.

Motahareh Rezvan, Amirhosein Kefayat, Mohammadmahdi Doostmohammadi

|Nov 23, 2025
Cross-Talk Between Tau O-GlcNAcylation and the Formation of the Early Driver of Neurodegeneration (Cis P-Thr231-Pro Tau) in Primary Cortical Neurons.

Leila Aghababaee, Khadijeh Farrokhi, Mohammad Hossein Karimi-Jafari

|Jan 09, 2023
A knowledge-based protein-protein interaction inhibition (KPI) pipeline: an insight from drug repositioning for COVID-19 inhibition.

Hossein Lanjanian, Shadi Hosseini, Zahra Narimani

|Sep 05, 2022
Inhibition Of Tau Protein Aggregation By a Chaperone-like β-Boswellic Acid Conjugated To Gold Nanoparticles.

Masoumeh Gharb, Amideddin Nouralishahi, Ali Riazi

|Mar 15, 2021
The brain 3β-HSD up-regulation in response to deteriorating effects of background emotional stress: an animal model of multiple sclerosis.

Sogol Meknatkhah, Monireh-Sadat Mousavi, Pouya Sharif Dashti

|Sep 11, 2020
The Changes in 1H-MRS Metabolites in Cuprizone-Induced Model of Multiple Sclerosis: Effects of Prior Psychological Stress.

Sogol Meknatkhah, Pouya Sharif Dashti, Samira Raminfard

Pageof 2

Frequent Collaborators

1 joint publications

Hossein Lanjanian

1 joint publications

Shadi Hosseini

1 joint publications

Zahra Narimani

1 joint publications

Sogol Meknatkhah